EUCTR2021-000633-14-CZ进行中（未招募）1 期
DYNAMICS OF POSTVACCINATION ANTI- SARS-COV-2 ANTIBODY RESPONSE IN EMPLOYES OF THE NATIONAL INSTITUTE OF PUBLIC HEALTH AND VOLUNTARIES 1-2021
Státní zdravotní ústav0 个研究点目标入组 300 人开始时间: 2021年2月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •those who were vaccinated in the vaccination centre of Státní zdravotní ústav and singed informed consent with participation in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 200
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •contraindications of vaccine application according to Summary of product characteristics
- •application of the first dose of the vaccine after the 1st of February 2021
研究者
相似试验
已完成
不适用
Changes in antibody titer after SARS-CoV-2 vaccination of patients with in-center and home dialysisJPRN-UMIN000046281Reiseikai Medical Corporation Shinagawa Garden Clinic96
尚未招募
不适用
A study on post- vaccination IgG antibody status among the healthcare workersCTRI/2021/03/031986Rajarajeswari medical college and hoapital
进行中（未招募）
不适用
Sarscov2 immunity Evaluation post-vaccination iN patIentS On Renal replacement therapyCOVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN52588893Royal Liverpool University Hospital750
尚未招募
不适用
Can vaccination produce protective antibodies in people who fail to develop protective antibodies after recovery from COVID-19 infectioCTRI/2021/04/032572Rajiv Gandhi Cancer Institute and Research Centre
已完成
4 期
SARS-CoV-2 antibody response after a booster dose of the mRNA COVID-19 vaccine (BNT162b2) among Thai children and adolescents aged 5-17 years.Healthy Thai children aged 5-17 years who received two doses of the mRNA vaccine (BNT162b2).children, Booster dose, Third vaccination, SARS-CoV-2, COVID-19, vaccines, mRNA vaccines, Adverse events, Vaccine safetyTCTR20230424002Siriraj Grant for Research Development150